Operating Lease, Right-of-Use Asset of BioXcel Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioXcel Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • BioXcel Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $140,000, a 70% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $140,000 -$321,000 -70% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $222,000 -$316,000 -59% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $303,000 -$310,000 -51% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $382,000 -$306,000 -44% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $461,000 -$301,000 -40% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $538,000 -$296,000 -35% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $613,000 -$293,000 -32% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $688,000 -$288,000 -30% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $762,000 -$283,000 -27% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $834,000 -$280,000 -25% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $906,000 -$275,000 -23% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $976,000 -$271,000 -22% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 $1,045,000 -$267,000 -20% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,114,000 -$263,000 -19% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,181,000 -$259,000 -18% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,247,000 -$264,000 -17% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $1,312,000 -$274,000 -17% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $1,377,000 +$276,000 +25% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $1,440,000 +$287,000 +25% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,511,000 +$318,000 +27% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $1,586,000 +$387,000 +32% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $1,101,000 -$145,000 -12% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $1,153,000 -$140,000 -11% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $1,193,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $1,199,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $1,246,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $1,293,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.